The number of people with susceptibility test result for rifampicin in Kazakhstan
Kazakhstan: The number of people with susceptibility test result for rifampicin was 5,121 in 2021. ▲ Rising
Latest (2021)
5,121
Change on year
up 5.4%
World rank
28th
of 155 countries
All-time high
6,298
in 2018
All-time low
3,831
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Kazakhstan, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Kazakhstan is 5,121, measured in 2021.
Compared with earlier readings it is up 5.4% on the previous year and up 33.7% over five years.
That places Kazakhstan 28th out of 155 countries with data for 2021, putting it in the top quarter.
The number of people with susceptibility test result for rifampicin in Kazakhstan, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 3,831 | — |
| 2018 | 6,298 | +64.4% |
| 2019 | 5,687 | -9.7% |
| 2020 | 4,858 | -14.6% |
| 2021 | 5,121 | +5.4% |
Kazakhstan compared with similar countries
- Kazakhstan's 5,121 is above the median for upper middle income countries, which is 880, 5.8× the median. (46 countries reporting)
- Kazakhstan's 5,121 is above the median for Europe & Central Asia, which is 229.5, 22.3× the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 5,272 | 3,831 | 6,298 | 3 |
| 2020s | 4,990 | 4,858 | 5,121 | 2 |
Countries ranked near Kazakhstan
- 25 Côte d'Ivoire 8,494 compare
- 26 Chad 7,424 compare
- 27 Sudan 6,193 compare
- 29 Uzbekistan 4,929 compare
- 30 United States of America 4,814 compare
- 31 Romania 4,366 compare
More health data for Kazakhstan
- Un projection of annual infant deaths, annual growth rate -1.35 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3158 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 825.8 deaths per 1,000 people (2090)
- Number of infants who die before age 1 660 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.58 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0485 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.16 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Kazakhstan?
- The number of people with susceptibility test result for rifampicin in Kazakhstan was 5,121 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Kazakhstan?
- The highest recorded value was 6,298 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Kazakhstan?
- The lowest recorded value was 3,831 in 2017.
- How does Kazakhstan rank for the number of people with susceptibility test result for rifampicin?
- Kazakhstan ranks 28th out of 155 countries with data for 2021.
- Where does this Kazakhstan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).